← All investor calls
LSP Health Economics
Series B: Health data & real-world evidence
€1M–€3M · Series B · Apply by 9 Aug 2026 (GMT +1)
Investor calls are for startup accounts. Sign in or create a startup profile →
About this opportunity
LSP Health Economics is actively investing in this space. Reimbursement-ready digital health with proven outcomes. We back founders with clinical evidence and a clear go-to-market.
- Investment stage
- Series B
- Typical ticket size
- €1M–€3M
Who should apply
- Therapeutic areas
- Oncology
- Service categories
- Real world evidenceData analytics and AI
- Geographic focus
- Find Startups in Specific Countries
- Regions
- North AmericaAfrica
- Startup stage
- Validation - MVP or BetaGrowth - Paid Pilots
- Maximum age
- Does not matter
- Business model
- Public pays (reimbursement)We are interested in all typesConsumer/patients pay
Application questions
- What traction and clinical evidence do you have?
- What are you raising and on what terms?
- Why is now the right time for your company?
- If accepted
- Promising startups are invited to a first call with the investment team.